Global Blood Therapeutics, Inc. Increase (Decrease) in Inventories
Global Blood Therapeutics, Inc. reported Increase (Decrease) in Inventories of $6.81 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2022-08-08
- Global Blood Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2022-06-30 was $3.42M, a 35.20% decline year-over-year.
- Global Blood Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2022-03-31 was $3.39M, a 116.06% increase year-over-year.
- Global Blood Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2021-12-31 was $6.25M, a 5.38% increase year-over-year.
- Global Blood Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2021-09-30 was $3.06M, a 48.34% decline year-over-year.
- Global Blood Therapeutics, Inc. increase (decrease) in inventories for fiscal 2021 was $16.15M, a 56.09% decline from fiscal 2020.
- Global Blood Therapeutics, Inc. increase (decrease) in inventories for fiscal 2020 was $36.78M, a 2780.11% increase from fiscal 2019.
- Global Blood Therapeutics, Inc. increase (decrease) in inventories for fiscal 2019 was $1.28M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2022-06-30 | $3.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $6.81M 10-Q · filed 2022-08-08 | $13.05M derived: sum of 3 quarters · filed 2022-08-08 | $16.11M derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | $3.39M 10-Q · filed 2022-05-04 | $9.63M derived: sum of 2 quarters · filed 2022-05-04 | $12.70M derived: sum of 3 quarters · filed 2022-05-04 | $17.97M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-12-31 | $6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $9.31M derived: sum of 2 quarters · filed 2022-02-23 | $14.58M derived: sum of 3 quarters · filed 2022-08-08 | $16.15M 10-K · filed 2022-02-23 |
| 2021-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $8.33M derived: sum of 2 quarters · filed 2022-08-08 | $9.90M 10-Q · filed 2021-11-04 | $15.83M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-06-30 | $5.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $6.84M 10-Q · filed 2022-08-08 | $12.77M derived: sum of 3 quarters · filed 2022-08-08 | $18.69M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $1.57M 10-Q · filed 2022-05-04 | $7.50M derived: sum of 2 quarters · filed 2022-05-04 | $13.42M derived: sum of 3 quarters · filed 2022-05-04 | $25.13M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $11.85M derived: sum of 2 quarters · filed 2022-02-23 | $23.56M derived: sum of 3 quarters · filed 2022-02-23 | $36.78M 10-K · filed 2022-02-23 |
| 2020-09-30 | $5.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $17.64M derived: sum of 2 quarters · filed 2021-11-04 | $30.85M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $11.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $24.93M 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | $13.22M 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $1.28M 10-K · filed 2022-02-23 |